Vogenx, Inc.

SEC filing

Pharmaceuticals · Raleigh, NC

Form D on EDGAR

Amount raised$750Ksold at filing

Total offering$5M$4.3M still open

Investors in the raise3count reported to the SEC

FiledJan 7, 2026first sale Dec 10, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

William WilkisonExecutive Officer, Director

Pete PieracciniDirector

Steven DelmarExecutive Officer, Director

Richard GormanDirector

Tim BorisDirector

James GreenExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.